Exelixis
EXEL
₹3,846
Share price
-2.65%
Change (1 day)
98.73%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Exelixis (EXEL) - Total debt
Total debt on the balance sheet as of March 2025 : ₹16.21 Billion
According to Exelixis's latest financial reports the company's total debt is ₹16.21 Billion. A company’s total debt is the sum of all current and non-current debts.
Exelixis - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | ₹16.37 B | 3.53% |
| 2023-12-31 | ₹15.81 B | 0.48% |
| 2022-12-31 | ₹15.73 B | 312.36% |
| 2021-12-31 | ₹3.81 B | 6.31% |
| 2020-12-31 | ₹3.58 B | 4.85% |
| 2019-12-31 | ₹3.42 B | 228.27% |
| 2018-12-31 | ₹1.04 B | 9.35% |
| 2017-12-31 | ₹0.95 B | -92.58% |
| 2016-12-31 | ₹12.85 B | -53.73% |
| 2015-12-31 | ₹27.77 B | 22.76% |
| 2014-12-31 | ₹22.62 B | 5.46% |
| 2013-12-31 | ₹21.45 B | 16.7% |
| 2012-12-31 | ₹18.38 B | 91.44% |
| 2011-12-31 | ₹9.60 B | 2.8% |
| 2010-12-31 | ₹9.34 B | 152.85% |
| 2009-12-31 | ₹3.69 B | -34.69% |
| 2008-12-31 | ₹5.65 B | 18.61% |
| 2007-12-31 | ₹4.76 B | -11.49% |
| 2006-12-31 | ₹5.38 B | -19.56% |
| 2005-12-31 | ₹6.69 B | 4.96% |
| 2004-12-31 | ₹6.38 B | 26.18% |
| 2003-12-31 | ₹5.05 B | 42.65% |
| 2002-12-31 | ₹3.54 B | 50.13% |
| 2001-12-31 | ₹2.36 B | 238.46% |
| 2000-12-31 | ₹0.69 B | 20.68% |
| 1999-12-31 | ₹0.57 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 GlaxoSmithKline GSK | ₹2.063 T | 12,627.21% | 🇬🇧 UK |
 Sanofi SNY | ₹1.973 T | 12,068.60% | 🇫🇷 France |
 Merck MRK | ₹3.019 T | 18,520.71% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹4.439 T | 27,282.23% | 🇺🇸 USA |
 Amgen AMGN | ₹4.972 T | 30,564.53% | 🇺🇸 USA |
 Johnson & Johnson JNJ | ₹4.527 T | 27,823.58% | 🇺🇸 USA |
 Pfizer PFE | ₹5.310 T | 32,654.04% | 🇺🇸 USA |
 Curis CRIS | ₹0.22 B | -98.59% | 🇺🇸 USA |
 AVEO Oncology
AVEO | ₹3.35 B | -79.33% | 🇺🇸 USA |